Literature DB >> 21856865

Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study.

Camille Laurent1, Sabina Müller, Catherine Do, Talal Al-Saati, Sophie Allart, Luigi Maria Larocca, Stefan Hohaus, Sophie Duchez, Anne Quillet-Mary, Guy Laurent, Pierre Brousset, Salvatore Valitutti.   

Abstract

CD8+ CTLs are thought to play a role in the control of follicular lymphoma (FL). Yet, the link between CTL tissue distribution, activation status, ability to kill FL cells in vivo, and disease progression is still elusive. Pretreatment lymph nodes from FL patients were analyzed by IHC (n = 80) or by 3-color confocal microscopy (n = 10). IHC revealed a rich infiltrate of CD8+ granzyme B+ (GrzB) cells in FL interfollicular spaces. Accordingly, confocal microscopy showed an increased number of CD3+CD8+GrzB+ CTLs and a brighter GrzB staining in individual CTL in FL samples compared with reactive lymph nodes. CTLs did not penetrate tumor nodules. In 3-dimensional (3-D) image reconstructions, CTLs were detected at the FL follicle border where they formed lytic synapse-like structures with FL B cells and with apoptotic cells, suggesting an in situ cytotoxic function. Finally, although GrzB expression in CTLs did not correlate with risk factors, high GrzB content correlated with prolonged progression free-survival (PFS) after rituximab-combined chemotherapy. Our results show the recruitment of armed CTLs with a tumor-controlling potential into FL lymph nodes and suggest that CTL-associated GrzB expression could influence PFS in FL patients having received rituximab-combined chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856865     DOI: 10.1182/blood-2011-04-345777

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.

Authors:  Chun Chao; Lanfang Xu; Michael J Silverberg; Otoniel Martínez-Maza; Lie-Hong Chen; Brandon Castor; Donald I Abrams; Hongbin D Zha; Reina Haque; Jonathan Said
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

2.  Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.

Authors:  Falko Fend; Leticia Quintanilla-Martínez
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

Review 3.  Pathogenesis of follicular lymphoma.

Authors:  Robert Kridel; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

Review 4.  Role of the microenvironment across histological subtypes of NHL.

Authors:  Karin Tarte
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets.

Authors:  Christopher R Bolen; Ronald McCord; Sarah Huet; Garrett M Frampton; Richard Bourgon; Fabrice Jardin; Peggy Dartigues; Elizabeth A Punnoose; Edith Szafer-Glusman; Luc Xerri; Pierre Sujobert; Gilles Salles; Jeffrey M Venstrom
Journal:  Blood Adv       Date:  2017-09-27

6.  Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.

Authors:  Camille Laurent; Bettina Fabiani; Catherine Do; Emmanuelle Tchernonog; Guillaume Cartron; Pauline Gravelle; Nadia Amara; Sandrine Malot; Maryknoll Mawanay Palisoc; Christiane Copie-Bergman; Alexandra Traverse Glehen; Marie-Christine Copin; Pierre Brousset; Stefania Pittaluga; Elaine S Jaffe; Paul Coppo
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

7.  CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells.

Authors:  Patricia Amé-Thomas; Sylvia Hoeller; Catherine Artchounin; Jan Misiak; Mounia Sabrina Braza; Rachel Jean; Jérôme Le Priol; Céline Monvoisin; Nadine Martin; Philippe Gaulard; Karin Tarte
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

8.  Impaired functional responses in follicular lymphoma CD8+TIM-3+ T lymphocytes following TCR engagement.

Authors:  Pauline Gravelle; Catherine Do; Camille Franchet; Sabina Mueller; Lucie Oberic; Loïc Ysebaert; Luigi Maria Larocca; Stefan Hohaus; Marie-Noëlle Calmels; François-Xavier Frenois; Robert Kridel; Randy D Gascoyne; Guy Laurent; Pierre Brousset; Salvatore Valitutti; Camille Laurent
Journal:  Oncoimmunology       Date:  2016-08-24       Impact factor: 8.110

9.  Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.

Authors:  Suresh Kalathil; Amit A Lugade; Austin Miller; Renuka Iyer; Yasmin Thanavala
Journal:  Cancer Res       Date:  2013-02-19       Impact factor: 12.701

Review 10.  Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.

Authors:  Shujing Shi; Longbang Chen; Guichun Huang
Journal:  Med Oncol       Date:  2013-08-28       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.